11/7/26 From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle Previous OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. Next From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment You Might Also Like The Plausible Mechanism Pathway: A New Evidence Playbook for Rare Disease Development Practical Application of Bayesian Networks in Rare Disease Trials OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. Patient Organizations as Evidence Partners: Shaping the Science Behind Rare Disease Approval Learning More from Less: Smarter Design and Execution in Rare Disease Trials
11/7/26 From Data to Discovery: Finding the Right Patients Across the Therapy Lifecycle Previous OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. Next From Awareness to Activation - Converting Rare Patient Identification into Trial Enrollment You Might Also Like The Plausible Mechanism Pathway: A New Evidence Playbook for Rare Disease Development Practical Application of Bayesian Networks in Rare Disease Trials OPENING KEYNOTE - From Breakthrough to Access: How Advocacy and Policy Decide What Reaches Patients. Patient Organizations as Evidence Partners: Shaping the Science Behind Rare Disease Approval Learning More from Less: Smarter Design and Execution in Rare Disease Trials
